NMRA
Arch Venture Partners Xii, Llc, NMRA's 10% owner, spent $5M of their own money on 1.92M shares at $3, growing their stake 46%.
+$5M
1.92M sh @ $3
NMRA
Neumora Therapeutics, Inc.
SEC CIK 1885522
$1.78
−11.9% · 90 days
90-day buys
$0
0 open-market
90-day sells
$0
0 open-market
Net insider flow
+$0
Net buying
Filings shown
21
Most recent
Advertisement
At a glance
Insiders at NMRA have made no open-market trades in the last 90 days — the activity below is grants, option exercises, and other routine filings.
Largest recent trade: Arch Venture Partners X, Llc, NMRA's 10% owner, spent $25.5M of their own money on 1.5M shares at $17, growing their stake 71%.
Most active filer: Arch Venture Partners Xii, Llc, with 19 transactions among the recent filings shown.
Insider transaction history
Form 4 filings for NMRA, newest firstNMRA
Arch Venture Partners X, Llc, NMRA's 10% owner, spent $5M of their own money on 1.92M shares at $3, growing their stake 46%.
+$5M
1.92M sh @ $3
NMRA
Arch Venture Partners Xii, Llc, NMRA's 10% owner, spent $40.2K of their own money on 3,357 shares at $12.
+$40.2K
3,357 sh @ $12
NMRA
Arch Venture Partners Xii, Llc, NMRA's 10% owner, spent $371.9K of their own money on 31,653 shares at $12, growing their stake 1%.
+$371.9K
31,653 sh @ $12
NMRA
Arch Venture Partners Xii, Llc, NMRA's 10% owner, spent $134.7K of their own money on 11,844 shares at $11.
+$134.7K
11,844 sh @ $11
Advertisement
NMRA
Arch Venture Partners Xii, Llc, NMRA's 10% owner, spent $63.8K of their own money on 5,431 shares at $12.
+$63.8K
5,431 sh @ $12
NMRA
Arch Venture Partners Xii, Llc, NMRA's 10% owner, spent $327.3K of their own money on 31,079 shares at $11, growing their stake 1%.
+$327.3K
31,079 sh @ $11
NMRA
Arch Venture Partners Xii, Llc, NMRA's 10% owner, spent $745.2K of their own money on 69,127 shares at $11, growing their stake 2%.
+$745.2K
69,127 sh @ $11
NMRA
Arch Venture Partners Xii, Llc, NMRA's 10% owner, spent $272.6K of their own money on 23,124 shares at $12, growing their stake 1%.
+$272.6K
23,124 sh @ $12
NMRA
Arch Venture Partners Xii, Llc, NMRA's 10% owner, spent $347.2K of their own money on 30,192 shares at $12, growing their stake 1%.
+$347.2K
30,192 sh @ $12
NMRA
Arch Venture Partners Xii, Llc, NMRA's 10% owner, spent $497.6K of their own money on 43,082 shares at $12, growing their stake 1%.
+$497.6K
43,082 sh @ $12
NMRA
Arch Venture Partners Xii, Llc, NMRA's 10% owner, spent $255.1K of their own money on 22,420 shares at $11, growing their stake 1%.
+$255.1K
22,420 sh @ $11
NMRA
Arch Venture Partners Xii, Llc, NMRA's 10% owner, spent $483.1K of their own money on 34,560 shares at $14, growing their stake 1%.
+$483.1K
34,560 sh @ $14
NMRA
Arch Venture Partners Xii, Llc, NMRA's 10% owner, spent $219.9K of their own money on 16,841 shares at $13.
+$219.9K
16,841 sh @ $13
NMRA
Arch Venture Partners Xii, Llc, NMRA's 10% owner, spent $343.8K of their own money on 25,110 shares at $14, growing their stake 1%.
+$343.8K
25,110 sh @ $14
NMRA
Arch Venture Partners Xii, Llc, NMRA's 10% owner, spent $301.6K of their own money on 24,504 shares at $12, growing their stake 1%.
+$301.6K
24,504 sh @ $12
NMRA
Arch Venture Partners Xii, Llc, NMRA's 10% owner, spent $398.8K of their own money on 34,000 shares at $12, growing their stake 1%.
+$398.8K
34,000 sh @ $12
NMRA
Arch Venture Partners Xii, Llc, NMRA's 10% owner, spent $332.3K of their own money on 30,773 shares at $11, growing their stake 1%.
+$332.3K
30,773 sh @ $11
NMRA
Arch Venture Partners Xii, Llc, NMRA's 10% owner, spent $349.1K of their own money on 29,967 shares at $12, growing their stake 1%.
+$349.1K
29,967 sh @ $12
NMRA
Arch Venture Partners Xii, Llc, NMRA's 10% owner, spent $445.6K of their own money on 40,000 shares at $11, growing their stake 1%.
+$445.6K
40,000 sh @ $11
NMRA
Arch Venture Partners X, Llc, NMRA's 10% owner, spent $25.5M of their own money on 1.5M shares at $17, growing their stake 71%.
+$25.5M
1.5M sh @ $17
Advertisement
About NMRA insider activity
This page tracks every recent Form 4 filed for Neumora Therapeutics, Inc. with the U.S. Securities and Exchange Commission. Form 4 is the disclosure that company insiders — officers, directors, and holders of more than 10% of the stock — must file within two business days of buying or selling shares.
The summary above nets open-market purchases against open-market sales over the trailing 90 days. Open-market trades (codes P and S) tend to carry the most signal because they reflect a deliberate choice to put money in or take it out, as opposed to routine grants, option exercises, or tax-withholding events. Use the badges on each row to tell them apart, and always confirm details against the original filing before drawing conclusions.
Frequently asked questions
How often is NMRA insider data updated?
Continuously. We read from SEC EDGAR, so new Form 4 filings for Neumora Therapeutics, Inc. usually appear here within minutes of being accepted by the SEC.
What does "net insider flow" mean?
It is the total dollar value of open-market insider purchases minus open-market sales over the last 90 days. A positive number (green) means insiders bought more than they sold; a negative number (red) means the reverse.
Why do some rows show grants or option exercises instead of buys?
Insiders receive stock through compensation as well as buying it outright. Form 4 captures all of these. We label each transaction by its SEC code so you can focus on open-market activity if you prefer.
Is this investment advice?
No. InsiderSource presents public filing data for informational purposes only. Insider activity is one of many factors to consider and is never a recommendation to buy or sell.